Research
- Research Programmes
- Researchers
- Postdoctoral & Research Fellows
- Featured Researchers
- Conway Fellows
- Conway Clinical Associate Fellows
- Conway Fellows (A-Z)
- Professor Mohamed Al-Rubeai
- Professor Alan Baird
- Dr. John Baugh
- Dr. Orina Belton
- Dr. Oliver Blacque
- Professor Billy Bourke
- Professor David Brayden
- Dr. Lorraine Brennan
- Professor Geraldine Butler
- Dr. Gerard Cagney
- Professor Dolores J. Cahill
- Professor Sean Callanan
- Dr. Marguerite Clyne
- Dr. John Crean
- Dr. Paul Crossey
- Professor Mark Crowe
- Professor Seamas Donnelly
- Professor Michael (Joe) Duffy
- Professor Jim Egan
- Professor Guiliano Elia
- Professor Paul Engel
- Professor Alex Evans
- Dr. Paul Evans
- Dr. Neil Ferguson
- Professor Oliver Fitzgerald
- Professor William Gallagher
- Professor Declan Gilheany
- Professor Catherine Godson
- Professor Stephen Gordon
- Professor Andrew Green
- Professor Patrick Guiry
- Dr. Jana Haase
- Dr. Chandralal Hewage
- Professor Des Higgins
- Professor Suzanne Jarvis
- Professor Michael Keane
- Dr. Breandan Kennedy
- Professor Boris Kholodenko
- Professor Therese Kinsella
- Professor Ulla Knaus
- Professor Walter Kolch
- Professor. Gil Lee
- Professor Brendan Loftus
- Professor Pat Lonergan
- Professor David MacHugh
- Dr. Patricia Maguire
- Professor Kevin Malone
- Professor J.Paul.G Malthouse
- Professor Finian Martin
- Dr. Margaret Mc Gee
- Professor Fionnuala McAuliffe
- Dr. Gethin McBean
- Dr. Amanda McCann
- Dr. Edward McKone
- Professor Paul McLoughlin
- Dr. Hilary McMahon
- Dr. Tara McMorrow
- Professor Walter McNicholas
- Professor Wim Meijer
- Dr. Anika Mostaert
- Professor Grace Mulcahy
- Dr. Keith Murphy
- Dr. Evelyn Murphy
- Dr. Jarlath Nally
- Professor Phillip Newsholme
- Dr. Jens Nielsen
- Dr. Peter O'Brien
- Dr. Kevin O'Connor
- Dr. John O'Connor
- Professor Ronan O'Connell
- Dr. Tadhg O'Croinin
- Dr. James O'Gara
- Professor Donal F. O'Shea
- Professor Stefan Oscarson
- Dr. Francesca Paradisi
- Professor William Powderly
- Professor Prem Puri
- Professor Ciaran Regan
- Professor Helen Roche
- Professor Pauline Rudd
- Professor Dimitri Scholz
- Dr. Noreen Sheehy
- Professor Denis Shields
- Professor Jeremy Simpson
- Dr. Albert Smolenski
- Dr. Matthias Tacke
- Professor Cormac Taylor
- Dr. Emma Teeling
- Professor Douglas Veale
- Professor Dominic Walsh
- Professor William Watson
- Professor Matthias Wilm
- Dr. Xiangming Zhu
- Core Technologies
Dr John Crean B.Sc., M.Sc., Ph.D.
Contact Details
|
 |
Biography:
| John is a UCD graduate (Biochemistry, B.Sc.). After completing his Masters in Clinical Biochemistry in Boston University and UCD, John joined the PhD programme at the University of Bristol under the direction of Professor Vic Duance in the Muscle and Collagen Research Centre. There began his love/hate relationship with matrix biology and fibrotic disease. Graduating in 1998, he joined the Matrix Group at R+D Systems in Oxford. He returned to academia in 2000, firstly at the University of Liverpool, and latterly in UCD under the guidance of Hugh Brady and Catherine Godson in the Mater Misericordiae Hospital. In 2002 he was awarded a HRB Career Development Fellowship and relocated to the laboratory of Finian Martin in the Biotechnology Centre in Belfield. In 2005, John joined the staff of Pharmacology, where he remains to this day. John is one of Principal Investigators in the SFI-funded Diabetes Research Centre, his group working mainly on aspects of cell-matrix interactions and matricellular signaling. His contributions to this field have included several important papers identifying receptors and downstream effector molecules belong to the CCN family. Their most recent studies have characterised interplay between receptor activated networks that regulate cell fate and differentiation in nephropathy, identifying an autocrine regulatory loop in TGFbeta signaling that plays a critical role in the regulation of fibrotic responses. |
Research Interests
| Statement of Research Interests
Dr. Crean has been engaged in research in the general area of cell-matrix interactions since completing his PhD in 1998, firstly in the biotechnology industry and latterly in an academic setting. Dr. Crean was a recipient of a Dublin Molecular Medicine Fellowship in 2001, enabling a return to academia in the Department of Medicine, University College Dublin. In 2005 he was awarded a prestigious Career Development Award and in 2007 was appointed to the Faculty of Science in University College Dublin as a tenure-track Lecturer in Pharmacology. He was subsequently awarded tenure in 2009. During this time he has been in receipt of >¿2,000,000 in funding from agencies including the Irish Health Research Board, Irish Research Council and Science Foundation Ireland among others. He has established himself as a world-leading expert on CCN proteins and has published extensively in this area. He first identified CTGF as a profibrotic mediator upregulated in both in vivo and in vitro models of DN and characterised the mechanism through which CTGF expression leads to matrix accumulation and cell migration. He also identified CTGF as a profibrotic mediator in other diseases. Among the notable outcomes from the SSH were a large number of actin binding and regulatory proteins. Follow-up studies used a focused cDNA array consisting of probe sets derived from the differentially regulated genes emerging from the SSH. CTGF stimulated the differential expression of a number of genes, of which the actin binding and regulatory protein cluster were prominent. Subsequent studies found that CTGF induced cell migration and dysregulation of the actin cytoskeleton, mediated by dephosphorylation of focal adhesion kinase and paxillin, loss of RhoA activity, activation of Cdc42, and phosphorylation of PKC-ζ and GSK-3β. He has also found that the myosin light chain kinase plays a key regulatory role in cell polarization. These observations suggest a mechanism wherein activity of members of the RhoGTPase family can be regulated by CTGF through PI 3-kinase mediated phosphorylation and translocation of p27, suggesting a genetic programme culminating in differential expression and activity of actin binding and regulatory proteins. Most recently, he has characterized the complex interaction between CTGF and TGFb identifying a mir302 regulatory loop. These studies have been published in leading journals including Journal of Biological Chemistry, The FASEB Journal, The Journal of Immunology, The Biochemical Journal and The Journal of Cell Science. Throughout this time, there has been a close collaborative link with Fibrogen Inc., culminating in the progression of the anti CTGF monoclonal antibody, FG-3019 into Stage II clinical trials for Diabetic Nephropathy. The rationale for anti CTGF directed therapeutics in fibrosis is well established; continuing efforts supported by this application and associated programmes are focused on more targeted strategies which can be better facilitated by a complete understanding of the relationship between the CTGF enriched fibrotic microenvironment and TGFb superfamily members. |
Research Projects
| Sponsor : Irish Research Council for Science Engineering and Technology (IRCSET) Fibrogen Inc USA Title : Modular signalling activities of the CTGF/CCN2 domain structure: Implications for therapeutic intervention Start Date / End Date : 15-DEC-08 / 14-DEC-11 |
| Sponsor : Science Foundation Ireland (SFI) Title : Mechanism of action of connective tissue growth factor: towards therapeutics in diabetic nephropathy Start Date / End Date : 01-SEP-07 / 29-FEB-12 |
| Sponsor : Fibrogen Inc USA Title : Studies on mechanism of action of CTGF Start Date / End Date : 01-JAN-07 / 31-DEC-11 |
Book Chapters
| Crean, JK., Brady, HR and Rabb, H.; (2004) 'Cell-cell and cell matrix interactions' In: Barry Brenner (eds). The Kidney. Philadelphia: Saunders, Elsevier. [Details] |
Peer Reviewed Journals
| Noel Faherty, Simon P. Curran, Helen O¿Donovan, Finian Martin1, Catherine Godson,Derek P. Brazil, and John Crean. (2012) 'CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes'. Journal of Cell Science, . [Details] |
| C. O'Donovan, Fionnuala Hickey, Derek P. Brazil, Noelynn Oliver, Finian Martin, Catherine Godson, and John Crean; (2012) 'Cross talk between connective tissue growth factor and transforming growth factor-Beta1 via interaction with the type III TGF-Beta receptor modulates mesangial cell behavior with pathogenic implications for diabetic nephropathy'. Biochem J, . [Details] |
| O'Donovan HC, Hickey F, Brazil DP, Kavanagh DH, Oliver N, Martin F, Godson C, Crean J.; (2011) 'Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells'. Biochem J, . [Details] |
| Smith, J. Meehan, M., Crean J. and McCann A; (2011) 'Alpha T-catenin (CTNNA3); A gene in the hand is worth two in the nest'. Cellular and Molecular Life Sciences, 68 (15):2493-2498. [Details] |
| Rooney, B,O'Donovan, H,Gaffney, A,Browne, M,Faherty, N,Curran, SP,Sadlier, D,Godson, C,Brazil, DP,Crean, J; (2011) 'CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy'. FEBS letters, 585 :531-538. [DOI] [Details] |
| Kavanagh DH, Savage DA, Patterson CC, McKnight AJ, Crean JK ; (2011) 'Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy'. PLoS ONE, 6 (8). [Details] | |||||||||
| Browne, JG., Ho, SL., Kadare, SJ., Kane, R., Oliver, N., Clark, AF., O'Brien, CJ., Crean, JK. ; (2010) 'The Effect Of CTGF On Trabecular Meshwork Cells And The Implications For Pseudoexfoliative Syndrome'. IOVS, . [Details] | |||||||||
| Rooney B, O'Donovan, H., Browne, M., Gaffney, A., Curran, SP., Brazil, DP. Godson, C., Sadlier, D and Crean, JK. ; (2010) 'CTGF/CCN2 activates canonical Wnt signaling in mesangial cells through LRP6; implications for the pathogenesis of diabetic nephropathy'. European journal of biochemistry / FEBS, . [Details] | |||||||||
| Nyhan KC, Faherty N, Murray G, Cooey LB, Godson C, Crean JK, Brazil DP.; (2010) 'Jagged/Notch signalling is required for a subset of TGFBeta1 responses in human kidney epithelial cells'. Biochima Et Biophysica Acta - Molecular Cell Research, 1803 :1386-1395. [Details] | |||||||||
| Brennan EP, Ehrich M, Brazil DP, Crean JK, Murphy M, Sadlier DM, Martin F, Godson C, van den Boom D, Maxwell AP, Savage DA.; (2010) 'DNA methylation profiling in cell models of diabetic nephropathy'. Epigenetics : official journal of the DNA Methylation Society, 16 (5). [Details] | |||||||||
| Brennan EP, Ehrich M, Brazil DP, Crean JK, Murphy M, Sadlier DM, Martin F,Godson C, McKnight AJ, van den Boom D, Maxwell AP, Savage DA. ; (2009) 'Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines'. Epigenetics : official journal of the DNA Methylation Society, 1 (4). [Details] | |||||||||
| Godson C, Murphy M, Crean J, Brazil DP, Sadlier D, Martin F, ; (2008) 'Regulation and consequences of differential gene expression in diabetic kidney disease'. Biochemical Society Transactions, Pt 5 (NA):941-945. [DOI] [Details] | |||||||||
| Mitchell, DM., Gaffney, A., Crean, JK., Kinsella, BT. and Godson C; (2007) 'The lipoxin A4 receptor is coupled to SHP-2 activation; implications for regulating growth factor receptor signalling'. Journal of Biological Chemistry, . [Details] | |||||||||
| Furlong, F,Crean, J,Thornton, L,O'Leary, R,Murphy, M,Martin, F; (2007) 'Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose'. American Journal of Physiology-Renal Physiology, 292 :1691-1700. [DOI] [Details] | |||||||||
| Crean, J.K., Furlong, F., Mitchell, D., McArdle E., Godson, C. and Martin, F.; (2006) 'Connective Tissue Growth Factor [CTGF]/CCN2 stimulates actin disassembly through Akt/protein kinase B (PKB) mediated phosphorylation and cytoplasmic translocation of p27Kip-1'. FASEB JOURNAL, 20 :1712-1714. [Details] | |||||||||
| Reville, K; Crean, JK; Vivers, S; Dransfield, I; Godson, C; ; (2006) 'Lipoxin A(4) redistributes myosin IIA and Cdc42 in macrophages: Implications for phagocytosis of apoptotic leukocytes'. Journal of Immunology, 176 (3):1878-1888. [Details] | |||||||||
| Ho, SL; Dogar, GF; Wang, J; Crean, J; Wu, QD; Oliver, N; Weitz, S; Murray, A; Cleary, PE; O'Brien, C; ; (2005) 'Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome'. British Journal of Ophthalmology, 89 (2):169-173. [Details] | |||||||||
| Kirwan, RP,Fenerty, CH,Crean, J,Wordinger, RJ,Clark, AF,O'Brien, CJ; (2005) 'Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro'. Molecular Vision, 11 :798-810. [Details] | |||||||||
| Kirwan, RP; Crean, JK; Fenerty, CH; Clark, AF; O'Brien, CJ; ; (2004) 'Effect of cyclical mechanical stretch and exogenous transforming growth factor-beta 1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head'. Journal of Glaucoma, 13 (4):327-334. [Details] | |||||||||
| Kirwan, RP; Crean, JK; Clark, A; O'Brien, CJ; ; (2004) 'The effect of transforming growth factor beta-1 (TGF-beta 1) on gene expression profiles in lamina cribrosa cells from the human optic nerve head'. Investigative Ophthalmology &Amp; Visual Science, 45 (NA):408-408. [Details] | |||||||||
| Crean JK, Furlong F, Finlay D, Mitchell D, Conway B, Brady HR, Godson C, Martin F.; (2004) 'Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization'. FASEB JOURNAL, 18 . [Details] | |||||||||
| Crean, J. K.,Furlong, F.,Finlay, D.,Mitchell, D.,Murphy, M.,Conway, B.,Brady, H. R.,Godson, C.,Martin, F.; (2004) 'Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization'. Faseb J, 18 (13):1541-3. [Details] | |||||||||
| Ho, S; Crean, J; Oliver, N; Klaus, S; O'Brien, C; ; (2003) 'Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome'. Investigative Ophthalmology &Amp; Visual Science, 44 (NA):519-519. [Details] | |||||||||
| Kirwan, RP; Crean, JK; Fenerty, C; Clark, AF; O'Brien, CJ; ; (2003) 'Differential gene expression in normal primary human lamina cribrosa cells exposed to cyclical mechanical stretch: A model for glaucomatous optic neuropathy'. Investigative Ophthalmology &Amp; Visual Science, 44 (NA):295-295. [Details] | |||||||||
| Crean, J; Finlay, B; Conway, B; Murphy, M; Godson, G; Brady, HR; Finian, M; ; (2003) 'CCN-2 (CTGF) induces actin rearrangement and mesangial cell motility: Involvement of RhoA and protein kinase C zeta'. Journal of the American Society of Nephrology, 14 (NA):129-129. [Details] | |||||||||
| Crean JK, Finlay D, Murphy M, Moss C, Godson C, Martin F, Brady HR; (2002) 'The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells'. Journal of Biological Chemistry, 27 (46):44187-44194. [Details] | |||||||||
| Crean, J. K.,Finlay, D.,Murphy, M.,Moss, C.,Godson, C.,Martin, F.,Brady, H. R.; (2002) 'The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells'. J Biol Chem, 277 (46):44187-94. [Details] | |||||||||
| Crean JK, Lappin D, Godson C, Brady HR; (2001) 'Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease'. Expert Opin. Ther. Targets, 5 (4):519-530. [Details] | |||||||||
| Devlin, HC; Crean, J; Fenerty, C; Clark, AF; O'Brien, C; ; (2001) 'Effects of mechanical stretch on the expression of MMPs and TIMPs by trabecular meshwork cells'. Investigative Ophthalmology &Amp; Visual Science, 42 (4):140-140. [Details] | |||||||||
| O'Brien, CJ; Fenerty, CH; Crean, JKG; Clark, AF; ; (2001) 'Production of matrix metalloprotease-2 by glauomatous and non-glaucomatous optic nerve astrocytes'. Investigative Ophthalmology &Amp; Visual Science, 42 (4):511-511. [Details] | |||||||||
| Crean JK, Duance VC, Sims TJ, Avery N, Smith S, Menage J, Eisenstein SM, Roberts S.; (1998) 'Changes in collagen cross-linking in degenerative disc disease and scoliosis'. Spine Journal, 23 (23):2545-2551. [Details] | |||||||||
| Crean JK, Roberts S, Eisenstein S and Duance V C; (1997) 'Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis'. Spine Journal, 22 (24):2877-2884. [Details] | |||||||||
| Crean JK, Roberts S, Eisenstein S and Duance V C; (1995) 'Matrix metalloproteinase levels in diseased human intervertebral disc'. Journal of Bone Joint Surgery, 3 :260-263. [Details] | |||||||||
| Hide | |||||||||
Other Journals
| Crean JK, Roberts S, Eisenstein SM and Duance VC; (1995) 'Matrix metalloproteinase levels in diseased human intervertebral disc' Arthritis and Rheumatism Research Communications(Lumbar Spine Disorders) 10 :38-40. [Details] |
Conference Publications
| Darrell Andrews, John Browne, Helen O¿Donovan, Noel Faherty, Noelynn Oliver, Deborah Wallace, Colm O¿Brien and John Crean. (2012) Integrated signalling between CTGF and TGF2 leads to divergent activation of canonical and non-canonical pathways controlling EMT in ARPE-19 cells: Implications for the pathogenesis of proliferative vitreoretinopathy ARVO [Details] |
| Kavanagh, D., Gaffney A., Murphy, M., Faherty, N., Andrews, D., Higgins, D., McKay, G., Maxwell, P., Godson, C. and Crean, J. (2012) Wnt 6 is increased in diabetic nephropathy and modulates de novo tubulogenesis and opposes TGFbeta mediated epithelial cell differentiation in vitro American Society of Nephrology [Details] |
| Noel Faherty, Simon P. Curran, Helen O¿Donovan, Finian Martin, Catherine Godson,Derek P. Brazil, and John Crean. (2011) CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes American Society of Nephrology [Details] |
| Rooney B, Gaffney, A., Godson, C., Sadlier, D and Crean, JK.; (2010) CTGF/CCN2 activates canonical Wnt signaling in mesangial cells through LRP6; implications for the pathogenesis of diabetic nephropathy American Society of Nephrology [Details] |
| O'Donovan, H. 1, Xu, L.3, Oliver, N.3, Godson, C.2, and Crean, JK; (2010) CTGF/CCN2 and TGFBeta Superfamily signalling: Implications for therapeutic intervention American Society of Nephrology [Details] |
| Browne, M., Faherty, N.1, Xu, L., Oliver, N., Brazil, D. , Godson, C. and Crean, J. ; (2010) Connective Tissue Growth Factor (CTGF) causes Cdc42 activation and altered actin binding protein expression in the glomerular podocyte American Society of Nephrology [Details] | |||||||||
| Godson C, Murphy M, Crean J, Brazil DP, Sadlier D, Martin F, ; (2008) Biochemical Society transactions Regulation and consequences of differential gene expression in diabetic kidney disease , pp.941-945 [DOI] [Details] | |||||||||
| Browne, M, Gaffney, A.*, O¿Leary, R., Furlong, F. *, Browne, J. *, Godson, C*., Martin, F. and Crean, JK (2007) A targeted cDNA microarray identifies cytoskeletal regulatory proteins as transcriptional targets of Connective Tissue Growth Factor (CTGF)/CCN2: Implications for diabetic nephropathy American Society of Nephrology [Details] | |||||||||
| Gaffney, A.*, Oliver, N.#, Godson, C.* and Crean, JK. (2007) FG3019 modulates CTGF-mediated mesangial cell adhesion and cytoskeletal signaling: implications for anti-CTGF directed therapeutic intervention American Society of Nephrology [Details] | |||||||||
| Crean, JK., Gaffney, A*., O¿Leary, R., Brown, P., Browne J., Devine, C., Martin, F. (2006) A targeted cDNA microarray identifies cytoskeletal regulatory proteins as transcriptional targets of Connective Tissue Growth Factor (CTGF)/CCN2: Implications for diabetic nephropathy American Society of Cell Biology [Details] | |||||||||
| Fiona Furlong, John Crean, Laura Thornton, Ronan O¿Leary, Madeline Murphy, and Finian Martin (2005) Constitutive Phosphorylation of GSK3 by High Extracellular Glucose Impairs CTGF Stimulated Cell Migration in Human Mesangial Cells American Society of Cell Biology [Details] | |||||||||
| Ho S, Crean J, Oliver N, Klaus S, O'Brien C. (2003) Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome ARVO [Details] | |||||||||
| Kirwan RP, Crean JK, Fenerty C, Clark AF, O'Brien.C (2003) Differential gene expression in normal primary human lamina cribrosa cells exposed to cyclical mechanical stretch: A model for glaucomatous optic neuropathy ARVO - The Association for Research in Vision and Ophthalmology [Details] | |||||||||
| Crean J, Finlay B, Conway B, Murphy M, Godson G, Brady HR, Martin, F (2003) CCN-2 (CTGF) induces actin rearrangement and mesangial cell motility: Involvement of RhoA and protein kinase C zeta American Society of Nephrology [Details] | |||||||||
| Crean JK, Finlay D, Martin F, Godson C, Brady HR (2002) The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration and actin cytoskeletal rearrangement in human mesangial cells American Society of Nephrology [Details] | |||||||||
| Crean JK, Finlay D, Godson C, Martin F, Brady HR (2002) Connective Tissue Growth Factor induces adhesion, contraction and cytoskeletal rearrangement in human mesangial cells: the role of Erk and Rho Kinases FASEB [Details] | |||||||||
| Devlin HC, Crean J, Fenerty C, Clark AF, O'Brien C. (2001) Effects of mechanical stretch on the expression of MMPs and TIMPs by trabecular meshwork cells ARVO [Details] | |||||||||
| O'Brien CJ, Fenerty CH, Crean J, Clark AF (2001) Production of matrix metalloprotease-2 by glauomatous and non-glaucomatous optic nerve astrocytes ARVO [Details] | |||||||||
| Hide | |||||||||
Dissertations/Theses
| Crean, J.K.,; (1998) The Collagenous Matrix of the Intervertebral Disc in Idiopathic Scoliosis and Other Degenerate Pathologies. Dissertations/Theses [Details] |
| Crean, J.K.,; (1993) Clot Lysis in the Upper Gastrointestinal Tract. Dissertations/Theses [Details] |
Presentation
| Crean JK, Finlay B, Conway B, Murphy M, Godson G, Brady HR, Martin, F ; (2003) CCN-2 (CTGF) induces actin rearrangement and mesangial cell motility: Involvement of RhoA and protein kinase C zeta. Presentation [Details] |
| Kirwan RP, Crean JK, Fenerty C, Clark AF, O'Brien.C; (2003) Differential gene expression in normal primary human lamina cribrosa cells exposed to cyclical mechanical stretch: A model for glaucomatous optic neuropathy. Presentation [Details] |
| Ho S, Crean J, Oliver N, Klaus S, O'Brien C.; (2003) Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Presentation [Details] |
| Crean JK, Finlay D, Martin F, Godson C, Brady HR; (2002) The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration and actin cytoskeletal rearrangement in human mesangial cells. Presentation [Details] |
| Crean JK, Finlay D, Godson C, Martin F, Brady HR; (2002) Connective Tissue Growth Factor induces adhesion, contraction and cytoskeletal rearrangement in human mesangial cells: the role of Erk and Rho Kinases. Presentation [Details] |
| Devlin HC, Crean J, Fenerty C, Clark AF, O'Brien C.; (2001) Effects of mechanical stretch on the expression of MMPs and TIMPs by trabecular meshwork cells. Presentation [Details] | |||||||||
| O'Brien CJ, Fenerty CH, Crean JKG, Clark AF; (2001) Production of matrix metalloprotease-2 by glauomatous and non-glaucomatous optic nerve astrocytes. Presentation [Details] | |||||||||
| Crean JK, Roberts S, Avery N, Sims T, Bailey AJ and Duance, VC; (1997) Structural and Functional implications of changes in collagen crosslinking in the human intervertebral disc. Presentation [Details] | |||||||||
| Crean JK, Roberts S, Eisenstein SM and Duance VC.; (1996) Turnover of the connective tissue matrix in diseased intervertebral disc. Presentation [Details] | |||||||||
| Hide | |||||||||
Honours and Awards
| Year: 1996. Title: Sofamor-Danek Award for Basic Science |
| Year: 1997. Title: Young Scientist of the Year |
Associations
| Association: International CCN Society, Function/Role: Member |
| Association: American Association for the Academy of Sciences, Function/Role: Member |
| Association: American Society for Experimental Biology, Function/Role: Member |
Committees
| Committee : UCD Human Research Ethics |
| Committee : UCD Conway Institute Imaging Steering Committee |
| Committee : Bachelor of Health and Life Sciences Programme Board |
| Committee : School of Biomolecular and Biomedical Sciences Teaching and Learning Committee |
Employment
| Employer: U.C.D. Position: Honorary Lecturer Medicine & Career track Investigator, Conway Institue |
| Employer: U.C.D. Position: Lecturer, HRB Career Development Fellow, Dept Medicine & Therapeutics |
| Employer: Mater Hospital, Dublin Position: Postdoctoral Fellow Dept. Medicine & Therapeutics |
| Employer: University of Liverpool Position: Postdoctoral Fellow Dept Veterinary Pathology |
| Employer: R+D Systems Europe Ltd Position: Postdoctoral Research Scientist |
| Employer: Uni. Bristol Position: Research Assistant, Muscle & Collagen Research Grp |
|||||||||
| Employer: Boston University Position: Research Associate Section of Gastroenterology |
|||||||||
| Employer: St.Vincents University Hospital Position: Lecturer (School of Nursing) Education & Research Cnt |
|||||||||
| Hide | |||||||||
Education
| Year 1993 Institution: University College Dublin Qualification: MSc Subject: |
| Year 1998 Institution: University of Bristol Qualification: PhD Subject: |
| Year 1990 Institution: University College Dublin Qualification: BSc Subject: |
Consultancy
| Client: : European Medicines Agency |
Outreach Activities
| SBBS representative Access Science 2008-09 |
Internal Collaborators
| Catherine Godson Finian Martin Breandan Kennedy Colm O'Brien |
External Collaborators
| David Liu Noelynn Oliver Roel Goldschmeding Volker Haase |